Agios Pharmaceuticals (NasdaqGS:AGIO) Q3 2025 Earnings Call October 30, 2025 08:00 AM ET Speaker2Good morning and welcome to Agios Pharmaceuticals third quarter 2025 conference call. At this time all participants are in a listen-only mode. There will be a question and answer session at the end. Please be advised that this call is being recorded at Agios' request. I would now like to turn the call over to Morgan Sanford, Head of Investor Relations at Agios. Please go ahead, ma'am.Speaker3Am.Speaker0Thank you ...